Special requirements for testing post-coital contraceptives.
D000818:Animals; D002986:Clinical Trials as Topic; D003281:Contraceptives, Postcoital / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000633:toxicity*; D006224:Cricetinae; D004341:Drug Evaluation / Q000592:standards; D004353:Drug Evaluation, Preclinical / Q000592:standards; D004967:Estrogens / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000633:toxicity; D005260:Female; D000882:Haplorhini; D006801:Humans; D007928:Lethal Dose 50; D051379:Mice; D011247:Pregnancy; D011372:Progestins / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000633:toxicity; D051381:Rats; D012098:Reproduction / Q000187:drug effects; D012107:Research Design
D003281:Contraceptives, Postcoital; D004967:Estrogens; D011372:Progestins